Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01263886. IPD Sharing: Not stated. Countries: 13. Publications: 0.
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT07218809. IPD Sharing: YES. Countries: 21. Publications: 0.
A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00516841. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer
ClinicalTrials.gov study NCT01967875. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT00003449. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian
ClinicalTrials.gov study NCT01952249. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC
ClinicalTrials.gov study NCT06475755. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
ClinicalTrials.gov study NCT01166542. IPD Sharing: Not stated. Countries: 13. Publications: 0.
Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT04731909. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT04300114. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy Study of CPC634 (CriPec® Docetaxel) in Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT03742713. IPD Sharing: NO. Countries: 3. Publications: 0.
Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT06856499. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon E
ClinicalTrials.gov study NCT04951648. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy
ClinicalTrials.gov study NCT04447118. IPD Sharing: NO. Countries: 13. Publications: 0.
PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors
ClinicalTrials.gov study NCT05357196. IPD Sharing: NO. Countries: 1. Publications: 0.
CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients
ClinicalTrials.gov study NCT03944902. IPD Sharing: YES. Countries: 1. Publications: 0.
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT03907527. IPD Sharing: NO. Countries: 1. Publications: 0.
An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer
ClinicalTrials.gov study NCT01869400. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy
ClinicalTrials.gov study NCT00005836. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Pembrolizumab Combined With Double Platinum Based Chemotherapy for Potentially Resectable NSCLC
ClinicalTrials.gov study NCT04324151. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.